科笛-B完成配售2890.4万股 净筹约2.4亿港元

Group 1 - The company completed a placement of shares on September 5, 2025, according to the terms and conditions of the placement agreement [1] - A total of 28.904 million shares were successfully placed to TruMed Health Innovation Fund LP, Octagon Investments Master Fund LP, and Octagon Private Opportunities Fund II LP [1] - The placement price was set at HKD 8.40 per share, resulting in total proceeds of approximately HKD 243 million [1][1]